GAM
MRVI icon

Gotham Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Gotham Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-347,015
Closed -$1.89M – 1627
2024
Q4 		$1.89M Sell
347,015
-120,833
-26% -$777K 0.02% 739
2024
Q3 		$3.89M Sell
467,848
-9,796
-2% -$84.7K 0.04% 562
2024
Q2 		$3.42M Sell
477,644
-65,944
-12% -$569K 0.04% 535
2024
Q1 		$4.71M Buy
543,588
+18,675
+4% +$126K 0.07% 380
2023
Q4 		$3.44M Buy
524,913
+900
+0.2% +$5.81K 0.06% 420
2023
Q3 		$5.24M Buy
524,013
+188,420
+56% +$2.07M 0.11% 239
2023
Q2 		$4.17M Sell
335,593
-18,340
-5% -$248K 0.09% 299
2023
Q1 		$4.96M Buy
353,933
+122,524
+53% +$1.76M 0.12% 202
2022
Q4 		$3.31M Buy
231,409
+120,232
+108% +$1.89M 0.09% 266
2022
Q3 		$2.84M Sell
111,177
-20,740
-16% -$520K 0.09% 285
2022
Q2 		$3.75M Buy
131,917
+97,787
+287% +$3.1M 0.12% 206
2022
Q1 		$1.2M Buy
34,130
+15,621
+84% +$524K 0.04% 509
2021
Q4 		$776K Buy
+18,509
New +$750K 0.03% 620
2021
Q2 		– Sell
-6,858
Closed -$244K – 1060
2021
Q1 		$244K Buy
+6,858
New +$227K 0.01% 893

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gotham Asset Management's MRVI Position: Q1 2025 in Review

Gotham Asset Management sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 347,015 shares — an estimated $1.89M sold.

Gotham Asset Management first reported a position in MRVI in Q1 2021 and held it in 14 quarters. The position peaked at $5.24M in Q3 2023. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

  • Gotham Asset Management reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Gotham Asset Management sold 347,015 Maravai LifeSciences shares in Q1 2025, an estimated $1.89M.
  • Gotham Asset Management first reported a position in Maravai LifeSciences in Q1 2021 and held it in 14 quarters.
  • Gotham Asset Management's Maravai LifeSciences position peaked at $5.24M in Q3 2023.
  • 184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Gotham Asset Management's 13F filing for Q1 2025, filed 15 May 2025.